{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:13Z","timestamp":1792787293367,"version":"4.5.0"},"reference-count":28,"publisher":"BMJ","issue":"5","funder":[{"name":"MINECO","award":["PI19\/00041"],"award-info":[{"award-number":["PI19\/00041"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>International consensus diagnostic criteria for idiopathic multicentric Castleman disease (iMCD) includes lymph node Castleman disease (CD) histopathological features as major criteria. Our aim was to apply those criteria in a series of 42 cases with CD to find differences among unicentric CD, iMCD, HHV-8+multicentric CD (HHV-8+MCD) and POEMS\/plasma cell neoplasia (PCN)-associated CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Available clinical and laboratory criteria were collected. Histopathological features (germinal centre hyperplasia\/regression, plasmacytosis, hypervascularity and follicular dendritic cell (FDC) prominence) were graded and immunohistochemistry with antibodies against CD20, CD3, CD138, HHV-8, Ig isotype (IgG, IgG4, IgA, IgM, IgD), kappa, lambda was performed in all cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen cases had hyaline-vascular type unicentric CD, 15 were HHV-8+MCD, 7 cases PCN\/POEMS-associated CD and 5 cases were iMCD. One case was consistent with systemic lupus erythematosus (SLE) lymphadenopathy. Differences in grading of the CD-associated histopathological features showed that FDC proliferation was prominent in unicentric CD, hypervascularity was increased in HHV-8 positive MCD and germinal centre hyperplasia was restricted to iMCD cases and SLE. Monotypic plasma cells were readily identifiable in the lymph node biopsies in 43% of PCN\/POEMS-associated CD. All three cases had lambda light chain restriction with IgA (two cases) and IgG (one case) isotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HHV-8+ MCD\u2009and PCN\/POEMS-related CD are the major mimickers of iMCD in lymph node biopsies. Grading of the five histopathological features for CD might be useful to, in conjunction with complete ancillary testing, suggest for specific disease entities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp-2022-208696","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T13:20:51Z","timestamp":1674480051000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers"],"prefix":"10.1136","volume":"77","author":[{"given":"Laura","family":"Rodriguez Merino","sequence":"first","affiliation":[{"name":"Pathology Department, Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana Avenda\u00f1o","family":"Pomares","sequence":"additional","affiliation":[{"name":"Translational Hematopathology\/IDIVAL, Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Revert","family":"Arce","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3565-8262","authenticated-orcid":false,"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[{"name":"Anatomic Pathology, Hospital Universitario Marques de Valdecilla, Universidad de Cantabria (UNICAN), Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"2025120518542672000_77.5.318.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-746933"},{"key":"2025120518542672000_77.5.318.2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25495"},{"key":"2025120518542672000_77.5.318.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.7.2130"},{"key":"2025120518542672000_77.5.318.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2007.03.002"},{"key":"2025120518542672000_77.5.318.5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"2025120518542672000_77.5.318.6","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318249dcdc"},{"key":"2025120518542672000_77.5.318.7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00784-017-2232-x","article-title":"Comprehensive analysis of 225 Castleman\u2019s diseases in the oral maxillofacial and neck region: a rare disease revisited","volume":"22","author":"He","year":"2018","journal-title":"Clin Oral Investig"},{"key":"2025120518542672000_77.5.318.8","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1182\/bloodadvances.2020003334","article-title":"International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease","volume":"4","author":"van Rhee","year":"2020","journal-title":"Blood Adv"},{"key":"2025120518542672000_77.5.318.9","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11112008","article-title":"Clinical and pathological characteristics of hyaline-vascular type unicentric castleman disease: a 20-year retrospective analysis","volume":"11","author":"Nishimura","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2025120518542672000_77.5.318.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2017.11.014"},{"key":"2025120518542672000_77.5.318.11","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw218"},{"key":"2025120518542672000_77.5.318.12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"2025120518542672000_77.5.318.13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/ejh.12191","article-title":"Human herpesvirus 8+ polyclonal igm\u03bb B-cell lymphocytosis mimicking plasmablastic leukemia\/lymphoma in HIV-infected patients","volume":"91","author":"Oksenhendler","year":"2013","journal-title":"Eur J Haematol"},{"key":"2025120518542672000_77.5.318.14","doi-asserted-by":"publisher","DOI":"10.1007\/BF01607150"},{"key":"2025120518542672000_77.5.318.15","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199711000-00004"},{"key":"2025120518542672000_77.5.318.16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41375-018-0323-6","article-title":"Recurrent PDGFRB mutations in unicentric Castleman disease","volume":"33","author":"Li","year":"2019","journal-title":"Leukemia"},{"key":"2025120518542672000_77.5.318.17","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.233"},{"key":"2025120518542672000_77.5.318.18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/TP.0000000000000801","article-title":"Fatal outcome of multiple clinical presentations of human herpesvirus 8-related disease after solid organ transplantation","volume":"100","author":"Vijgen","year":"2016","journal-title":"Transplantation"},{"key":"2025120518542672000_77.5.318.19","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13518","article-title":"Human herpesvirus 6, 7, and 8 in solid organ transplantation: guidelines from the american society of transplantation infectious diseases community of practice","volume":"33","author":"Pellett Madan","year":"2019","journal-title":"Clin Transplant"},{"key":"2025120518542672000_77.5.318.20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ajh.26240","article-title":"Poems syndrome: 2021 update on diagnosis, risk-stratification, and management","volume":"96","author":"Dispenzieri","year":"2021","journal-title":"Am J Hematol"},{"key":"2025120518542672000_77.5.318.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-316935"},{"key":"2025120518542672000_77.5.318.22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.semdp.2016.05.006","article-title":"Multicentric castleman disease: where are we now?","volume":"33","author":"Wang","year":"2016","journal-title":"Semin Diagn Pathol"},{"key":"2025120518542672000_77.5.318.23","doi-asserted-by":"crossref","first-page":"10301","DOI":"10.3390\/ijms231810301","article-title":"Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric castleman disease","volume":"23","author":"Nishikori","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025120518542672000_77.5.318.24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3960\/jslrt.22011","article-title":"Idiopathic plasmacytic lymphadenopathy: a conceptual history along with a translation of the original Japanese article published in 1980","volume":"62","author":"Takeuchi","year":"2022","journal-title":"J Clin Exp Hematop"},{"key":"2025120518542672000_77.5.318.25","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.72"},{"key":"2025120518542672000_77.5.318.26","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.54"},{"key":"2025120518542672000_77.5.318.27","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.082958"},{"key":"2025120518542672000_77.5.318.28","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.17"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2022-208696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:54:35Z","timestamp":1764989675000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2022-208696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,18]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/jcp-2022-208696"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2022-208696","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}